These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35339658)

  • 1. Seroprevalence of Cytomegalovirus antibodies and primary infection among hemodialysis patients: A systematic and meta-analysis review.
    Mesgar Saravi N; Mousavi T
    Transpl Immunol; 2022 Jun; 72():101587. PubMed ID: 35339658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey the seroprevalence of CMV among hemodialysis patients in Urmia, Iran.
    Sepehrvand N; Khameneh ZR; Eslamloo HR
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):363-7. PubMed ID: 20228534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus seroprevalence among blood donors: a systematic review and meta-analysis.
    Adane T; Getawa S
    J Int Med Res; 2021 Aug; 49(8):3000605211034656. PubMed ID: 34382466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Cytomegalovirus Antibodies in the Serum of Hemodialysis Patients.
    Ibrahim MN; Alhadi MS; Elbadawy WY; Al-Sharari MS; Al-Ruwali HM; Al-Anazi TM
    Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of VZV IgG antibody in kidney transplant recipients: A systematic and meta-analysis review.
    Alimohammadi M; Moosazadeh M; Mardomi A; Mousavi T
    Transpl Immunol; 2022 Dec; 75():101730. PubMed ID: 36341911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the impact of cytomegalovirus seropositivity on blood parameters in renal hemodialysis patients.
    Emad R; Badr-Aldin WY; Anani M; Marei YE; Sakr MG; Ibrahim GA
    Egypt J Immunol; 2024 Jul; 31(3):113-122. PubMed ID: 38995716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroepidemiology of cytomegalovirus infections in Croatia.
    Vilibic-Cavlek T; Kolaric B; Beader N; Vrtar I; Tabain I; Mlinaric-Galinovic G
    Wien Klin Wochenschr; 2017 Feb; 129(3-4):129-135. PubMed ID: 27599701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of cytomegalovirus infection among patients undergoing hemodialysis.
    Abou-El-Yazed E; El-Hoseny IM; Kasim K; El-Sadek AA; Morsy ; Amar A
    Egypt J Immunol; 2008; 15(2):33-41. PubMed ID: 20306686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of Cytomegalovirus Infection Among HIV-Infected and HIV-Uninfected Pregnant Women Attending Antenatal Clinic in Harare, Zimbabwe.
    Mhandire D; Duri K; Kaba M; Mhandire K; Musarurwa C; Chimusa E; Munjoma P; Mazengera L; Stray-Pedersen B; Dandara C
    Viral Immunol; 2019 Sep; 32(7):289-295. PubMed ID: 31347990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey].
    Ataman S; Colak D; Günseren F; Senol Y; Colak T; Aktekin MR; Gültekin M
    Mikrobiyol Bul; 2007 Oct; 41(4):545-55. PubMed ID: 18173073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of cytomegalovirus antibodies among blood donors and Multitransfused recipients--a study from north India.
    Das B; Kaur G; Basu S
    Transfus Apher Sci; 2014 Jun; 50(3):438-42. PubMed ID: 24675015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus seroprevalence in women with bad obstetric history in Kirkuk, Iraq.
    Aljumaili ZK; Alsamarai AM; Najem WS
    J Infect Public Health; 2014; 7(4):277-88. PubMed ID: 24629348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes Group Viruses: a Seroprevalence Study in Hemodialysis Patients.
    Vilibić-Čavlek T; Kolarić B; Bogdanić M; Tabain I; Beader N
    Acta Clin Croat; 2017 Jun; 56(2):255-261. PubMed ID: 29485792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of cytomegalovirus antibodies in blood donors in southern, Brazil.
    Souza MA; Passos AM; Treitinger A; Spada C
    Rev Soc Bras Med Trop; 2010; 43(4):359-61. PubMed ID: 20802930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.
    Just-Nübling G; Korn S; Ludwig B; Stephan C; Doerr HW; Preiser W
    Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus Infection among Pregnant Women in Beijing: Seroepidemiological Survey and Intrauterine Transmissions.
    Jin Q; Su J; Wu S
    J Microbiol Biotechnol; 2017 May; 27(5):1005-1009. PubMed ID: 28285497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of cytomegalovirus IgG antibodies among pregnant women in Japan from 2009-2014.
    Shigemi D; Yamaguchi S; Otsuka T; Kamoi S; Takeshita T
    Am J Infect Control; 2015 Nov; 43(11):1218-21. PubMed ID: 26277571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of CMV IgG and IgM in Korean women of childbearing age.
    Choi R; Lee S; Lee SG; Lee EH
    J Clin Lab Anal; 2021 Apr; 35(4):e23716. PubMed ID: 33783845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus infection in a cohort of pregnant women.
    El Sanousi SM; Osman ZA; Mohmed AB; Al Awfi MS
    Am J Infect Control; 2016 Apr; 44(4):e41-3. PubMed ID: 26810886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seroprevalence and detection of primary infection by cytomegalovirus with IgG avidity test during the first quarter of pregnancy].
    González-García CL; Reyes-Méndez MA; Ortega-Pierres LE; Rodríguez-Sánchez AP; Sandoval-Guido V; Sereno-Coló JA
    Salud Publica Mex; 2014; 56(6):619-24. PubMed ID: 25604413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.